cis,cis‐Ceratospong­amide N,N‐di­methyl­acet­amide hemisolvate in the presence of twinning

Ceratospong­amide (CS) is a potent inhibitor of secreted phospho­lipase A₂, and cis,cis and trans,trans isomers, related with respect to the two proline amide bonds, are known. Crystals of cis,cis‐CS were grown from N,N‐di­methyl­acet­amide solution, giving the title compound, the cyclic ester of isoleucyl­oxazolinyl­phenyl­alanyl­prolyl­thia­zolyl­phenyl­alanyl­pro­line [cyclo(‐Ile–Oxz–Phe–Pro–Thz–Phe–Pro‐)] N,N‐di­methyl­acet­amide hemisolvate, C₄₁H₄₉N₇O₆S·0.5C₄H₉NO. The structure is the third example of cis,cis‐CS to be investigated and comprises twinned crystals, in which the a and b axes are interchanged. The ratio of co‐existing twin crystals is approximately 50%. The peptide has a `saddle‐like' structure and is very similar to previously reported structures of cis,cis‐CS, which implies that the structure of cis,cis‐CS is very stable in spite of differences in crystallization conditions.     

2,4‐Di­nitro­phenyl­hydrazones of 2,4‐di­hydroxy­benz­aldehyde, 2,4‐di­hydroxy­aceto­phenone and 2,4‐di­hydroxy­benzo­phenone

In 2,4‐di­hydroxy­benz­aldehyde 2,4‐di­nitro­phenyl­hydrazone N,N‐di­methyl­form­amide solvate {or 4‐[(2,4‐di­nitro­phenyl)­hydrazono­methyl]­benzene‐1,3‐diol N,N‐di­methyl­form­amide solvate}, C₁₃H₁₀N₄O₆·C₃H₇NO, (X), 2,4‐di­hydroxy­aceto­phenone 2,4‐di­nitro­phenyl­hydrazone N,N‐di­methyl­form­am­ide solvate (or 4‐{1‐[(2,4‐di­nitro­phenyl)hydrazono]ethyl}benzene‐1,3‐diol N,N‐di­methyl­form­amide solvate), C₁₄H₁₂N₄O₆·C₃H₇NO, (XI), and 2,4‐di­hydroxy­benzo­phenone 2,4‐di­nitro­phenyl­hydrazone N,N‐di­methyl­acet­amide solvate (or 4‐­{[(2,4‐di­nitro­phenyl)hydrazono]phenyl­methyl}benzene‐1,3‐diol N,N‐di­methyl­acet­amide solvate), C₁₉H₁₄N₄O₆·C₄H₉NO, (XII), the molecules all lack a center of symmetry, crystallize in centrosymmetric space groups and have been observed to exhibit non‐linear optical activity. In each case, the hydrazone skeleton is fairly planar, facilitated by the presence of two intramolecular hydrogen bonds and some partial N—N double‐bond character. Each molecule is hydrogen bonded to one solvent mol­ecule.     

1d‐3,4‐Di‐O‐(di­phenyl­methylphos­pho­nio)‐1,2,5,6‐tetra‐O‐methyl‐chiro‐inositol diiodide

The title compound, 3,4,5,6‐tetra­methoxy­cyclo­hexane‐1,2‐diyl­dioxy­bis­(methyl­di­phenyl­phospho­nium) diiodide, C₃₆­H₄₄­O₆­P₂²⁺·­2I^?, was prepared from a New Zealand natural product, d ‐chiro‐inositol, in order to develop new catalytic metal complexes. The inositol ring retains its usual chair conformation with only minor perturbations caused by the bound di­phenyl­methyl­phosphines. Crystal‐packing forces are provided by C—H?I cation–anion interactions.     

A bis‐copper(II)–[d‐βVal3,7]ascidiacyclamide complex enveloping two square pyramids and sharing an apex atom from a carbonate anion

The four azole rings place structural restrictions on ascidiacyclamide (ASC). As a result, the structure of ASC exists in an equilibrium between two major forms (i.e. folded and square). [d ‐βVal^3,7]Ascidiacyclamide (βASC) was synthesized by replacing two d ‐Val‐Thz (Val is valine and Thz is thiazole) blocks with d ‐β‐Valine (D‐βVal‐Thz). This modification expands the peptide ring; the original 24‐membered macrocycle of ASC becomes a 26‐membered ring. Circular dichroism (CD) spectra showed that, in solution, the structural equilibrium is maintained with βASC, but the folded form is dominant. A copper complex was prepared, namely [[d ‐βVal^3,7]ascidiacyclamide(2?)]aqua‐μ‐carbonato‐dicopper(II) monohydrate, [Cu₂(C₃₈H₅₄N₈O₆S₂)(CO₃)(H₂O)]·H₂O, to determine the effect of the change in ring size on the coordinated structure. The obtained bis‐Cu^II–βASC complex contains two water molecules and a carbonate anion. Two Cu^II ions are chelated by three N‐donor atoms of two Thz–Ile–Oxz (Ile is isoleucine and Oxz is oxazoline) units. An O atom of the carbonate anion bridges two Cu^II ions, forming two square pyramids. These features are similar to the previously reported structure of the Cu^II–ASC complex, but the two pyramids are enveloped inside the peptide and share one apex. In the Cu^II–ASC complex, the apex of each square pyramid is an O atom of a water molecule, and the two pyramids are oriented toward the outside of the peptide. The incorporated β‐amino acids of βASC make the space inside the peptide large enough to envelop the two square pyramids. The observed structural changes in the bis‐Cu^II–βASC complex arising from ring expansion are particularly interesting in the context of the previously reported structure of the Cu^II–ASC complex.     

Packing considerations of bis‐dimedone derivatives

We have determined the crystal structures of 2,2′‐(4‐fluoro­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₇FO₄, (I), 2,2′‐(4‐chloro­phenyl)­methyl­enebis(3‐hy­droxy‐5,5‐dimethyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₇ClO₄, (II), 2,2′‐(4‐hydroxy­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₃H₂₈O₅, (III), 2,2′‐(4‐methyl­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₄H₃₀O₄, (IV), 2,2′‐(4‐methoxy­phenyl)­methyl­enebis(3‐hy­droxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₄H₃₀O₅, (V), and 2,2′‐(4‐N,N′‐di­methyl­amino­phenyl)­methyl­enebis(3‐hydroxy‐5,5‐di­methyl‐2‐cyclo­hexen‐1‐one), C₂₅H₃₃NO₄, (VI). Structures (III) to (VI) of these bis‐dimedone derivatives show nearly the same packing pattern irrespective of the different substituent in the para position of the aromatic ring. However, (II) does not fit into this scheme, although the Cl atom is a substituent not too different from the others. The different packing of the fluoro compound, (I), can be explained by the fact that it crystallizes with two mol­ecules in the asymmetric unit, which show a different conformation of the dimedone ring. On the other hand, (I) shows a similar packing pattern to bis(2‐hydroxy‐4,4‐di­methyl‐6‐oxo‐1‐cyclo­hexenyl)­phenyl­methane, a compound containing an aromatic ring without any substituent and with Z′ = 2.     

Two 5‐oxa‐2,6‐diazaspiro[3.4]octan‐1‐one derivatives from the [3+2] cyclo­addition of methylenelactams with nitrones

The two title 5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one adducts, 7‐benzoyl‐2‐(4‐methoxy­phenyl)‐6‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₅H₂₂N₂O₄, (III), and 6‐tert‐butyl‐2‐(4‐methyl­phenyl)‐7‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₂H₂₆N₂O₂, (IV), were obtained from a stereospecific [3+2] 1,3‐cyclo­addition of 3‐methyl­ene azetidin‐2‐ones as dipolaro­philes with nitro­nes. The lactam ring is conjugated with the p‐­methoxy­phenyl or p‐methyl­phenyl moiety. The envelope conformations of the isoxazolidine rings in (III) and (IV) are different, leading the substituents to be pseudo‐axial in (III) and pseudo‐equatorial in (IV).     

A silaproline‐containing dipeptide

The silaproline‐containing dipeptide N‐(3,3‐di­methyl‐1‐pivaloyl‐1‐aza‐3‐sila‐5‐cyclo­pentyl­carbonyl)‐l ‐alanine iso­propyl­amide, C₁₇H₃₃N₃O₃Si, has two independent molecules in the asymmetric unit and each adopts a β‐II folded conformation, where the amide on the terminal C interacts intramolecularly with the pivaloyl O atom. The five‐membered silaproline ring is C^β‐puckered, an infrequent conformation for the homol­ogous proline ring.     

A complex containing both five‐ and six‐coordinate [bis(5‐bromosalicyli­dene)benzene‐1,2‐diimine]chloro­iron(III)

The title compound, aqua­chloro{4,4′‐di­bromo‐2,2′‐[o‐phenylenebis­(nitrilo­methyl­idyne)]­diphenolato‐O,N,N′,O′}iron(III)–chloro{4,4′‐di­bromo‐2,2′‐[o‐phenyl­enebis­(nitrilomethyli‐dyne)]diphenolato‐O,N,N′,O′}iron(III)–di­methyl­form­amide (1/1/1), [FeCl(C₂₀H₁₂Br₂N₂O₂)][FeCl(C₂₀H₁₂Br₂N₂O₂)(H₂O)]·C₃H₇NO, contains one independent five‐coordinate [FeCl(C₂₀H₁₂Br₂N₂O₂)] monomer, one six‐coordinate [FeCl(C₂₀H₁₂Br₂N₂O₂)(H₂O)] monomer and a non‐coordinating di­methyl­form­amide solvent mol­ecule in the asymmetric unit. In the five‐coordinate monomer, the Fe atom shows distorted square‐pyramidal geometry, with the N and O atoms of the ligand at the base and the Cl atom at the apex of the pyramid. In the six‐coordinate monomer, the Fe atom is in a distorted octahedral geometry and coordinated by the donor atoms of the tetrafunctional ligand in the horizontal plane, and the coordination sphere is completed by the O atom of the water mol­ecule and the Cl atom at the axial positions. The title compound contains intermolecular O—H?O hydrogen bonds. Apart from these hydrogen bonds, there are also intermolecular C—H?Cl and C—H?O contacts.     

trans‐[N,N′‐Bis­(salicyl­idene)­cyclo­hexane‐1,2‐diaminato]­nickel(II)–chloro­form (1/1)

In the title complex, trans‐{2,2′‐[cyclo­hexane‐1,2‐diyl­bis­(ni­t­rilo­methyl­idyne)]­di­phenol­ato‐κ⁴O,N,N′,O′}­nickel(II)–chloro­form (1/1), [Ni(C₂₀H₂₀N₂O₂)]·CHCl₃, the Ni atom has a square‐planar geometry, slightly tetrahedrally distorted. The Ni—N and Ni—O bonding distances are within the expected ranges for Ni–Schiff base derivatives. The di­imine bridge has a gauche conformation with the cyclo­hexyl ring almost coplanar with the NiN₂O₂ plane. The complex mol­ecules pack in dimers with an Ni?Ni distance of 3.59 (1) Å and form a three‐dimensional structure displaying a herring‐bone configuration. Channels are occupied by solvent mol­ecules, which are involved in C—H?O hydrogen bonds with the ligand O atoms.     

A dimeric constrained‐geometry titanium complex linked by double Ti–CH2–Al–CH2 heterocycles

In the structure of bis({N‐[di­methyl(1η⁵‐2,3,4,6‐tetra­methyl­in­den­yl)­silyl]­cyclo­hexyl­amido‐1κN}(methyl‐3κC)‐di‐μ₃‐methyl­ene‐1:2:3κ³C;1:3:3′κ³C‐tris(pentafluorophenyl‐2κC)titanium) benzene disolvate, [Me₂Si(η⁵‐2,3,4,6‐Me₄C₉H₂)(C₆H₁₁N)]Ti[(μ₃‐CH₂)Al(C₆F₅)₃][AlMe(μ₃‐CH₂)]₂ or [Ti₂(C₂₁H₇AlF₁₅)₂(C₂₁H₃₁NSi)₂]·2C₆D₆, the dimer is located on an inversion center, and the two Ti centers are linked by double Ti(μ₃‐CH₂)Al(C₆F₅)₃AlMe(μ₃‐CH₂) heterocycles. The electron‐deficient Ti centers are further stabilized by two α‐agostic interactions between Ti and one H atom of each bridging methyl­ene group.     

Stereochemistry of two new polyfunctionalized gem‐dihalo­cyclo­propanes

The two new gem‐dihalogeno­cyclo­propanes (1′S,3R)‐3‐(2′,2′‐di­chloro‐1′‐methyl­cyclo­propyl)‐6‐oxoheptanoic acid, C₁₁H₁₆­Cl₂O₃, (2), and (1′S,3R)‐3‐(2′,2′‐di­bromo‐1′‐methyl­cyclo­propyl)‐6‐oxoheptanoic acid, C₁₁H₁₆Br₂O₃, (3), are isostructural. Both present two stereogenic centers at C1′ and C3. The absolute configuration was determined by X‐ray methods. The cyclo­propyl rings are unsymmetrical, the shortest bond being distal with respect to the alkyl‐substituted C atom.     

5,5′‐Di‐tert‐butyl‐2,2′‐di­hydroxy‐3,3′‐methyl­enedibenz­aldehyde and 6,6′‐di‐tert‐butyl‐8,8′‐methyl­ene­bis­(spiro­[4H‐1,3‐benzodioxin‐2,1′‐cyclo­hexane])

Two related compounds containing p‐tert‐butyl‐o‐methyl­ene‐linked phenol or phenol‐derived subunits are described, namely 5,5′‐di‐tert‐butyl‐2,2′‐di­hydroxy‐3,3′‐methyl­ene­di­benz­aldehyde, C₂₃H₂₈O₄, (I), and 6,6′‐di‐tert‐butyl‐8,8′‐methyl­ene­bis­(spiro­[4H‐1,3‐benzo­di­oxin‐2,1′‐cyclo­hexane]), C₃₅H₄₈O₄, (II). Both compounds adopt a `butterfly' shape, with the two phenol or phenol‐derived O atoms in distal positions. Phenol and aldehyde groups in (I) are involved in intramolecular hydrogen bonds and the two dioxin rings in (II) are in distorted half‐chair conformations.     

Azido­[1,1′‐bis­(di­phenyl­phosphino)­ferrocene](penta­methyl­cyclo­penta­dienyl)­rhodium(III) hexa­fluoro­phosphate

In the title compound, azido‐2κN‐bis­[μ‐(1η⁵:2κP)‐di­phenyl­phosphino­cyclo­penta­dienyl][2(η⁵)‐penta­methyl­cyclo­penta­di­enyl]­iron(III)­rhodium(III) hexa­fluoro­phosphate, [{Rh(C₁₀H₁₅)(N₃)}{Fe(μ‐C₁₇H₁₄P)₂}]PF₆ or [FeRh(C₁₀H₁₅)(μ‐C₁₇H₁₄P)₂(N₃)]PF₆, the coordination sphere of Rh^III can be described as pseudo‐tetrahedral, composed of two P atoms from a 1,1′‐bis­(di­phenyl­phosphino)­ferrocene (dppf) ligand, an azido N atom and the centroid of the ring of a C₅Me₅ (Cp*) ligand. The two cyclo­penta­dienyl rings in the dppf moiety adopt an eclipsed conformation. The Rh⋯Fe distance is 4.340 (2) Å.     

Two 2,2‐dihalo‐N‐(1‐phenyl­ethyl)­cyclo­propane‐1‐carbox­amides

The crystal structures of (1R,1′S)‐2′,2′‐di­chloro‐N‐(1‐phenyl­ethyl)­cyclo­propane‐1′‐carbox­amide, C₁₂H₁₃Cl₂NO, (I), and (1R,1′R)‐2′,2′‐di­fluoro‐N‐(1‐phenyl­ethyl)­cyclo­propane‐1′‐car­box­amide, C₁₂H₁₃F₂NO, (II), have been determined. Both crystals contain two independent mol­ecules with different conformations of the phenyl­ethyl groups. In the crystals of both compounds, the mol­ecules are linked together by N—H⃛O hydrogen bonds, thus forming chains in the a direction.     

Intermolecular interactions and ­molecular geometry in molecular complexes of N,N‐di­methyl­aniline: the 1:1 complex with 1,2,4,5‐tetra­cyano­benzene

The partner mol­ecules of N,N‐di­methyl­aniline–1,2,4,5‐tetra­cyano­benzene (1/1), C₈H₁₁N·C₁₀H₂N₄, are stacked alternately in infinite columns. The N atom of the N,N‐di­methyl­aniline mol­ecule has a partially tetrahedral character and the distance between neighbouring mol­ecules in the stack is relatively short on the side where the lone‐pair electrons of this atom are located. Molecular‐packing analysis of this and three other complexes of N,N‐di­methyl­aniline shows that there is a close relationship between the strength of the intermolecular interaction on this side and the tetrahedral character of the N atom.     

Self‐assembly of 2‐pivaloyl‐6‐chloro­pterin

In the title compound, N‐(6‐chloro‐4‐oxo‐3,4‐di­hydro­pteridin‐2‐yl)­‐2,2‐di­methyl­propan­amide, C₁₁H₁₂ClN₅O₂, the rings in the pterin moiety are planar. The amide carbonyl O atom is in syn‐periplanar conformation while the C—N—C—C propanamide linkage is antiperiplanar. The N—H?N and N—H?O intermolecular hydrogen bonds transform the mol­ecules into infinite chains.     

Disappearance of intramolecular stacking due to one‐atom movement or increment of a `propyl­ene linker' in pyrazolo­[3,4‐d]­pyrimidine‐based ­flexible models

In the crystal structures of 4,6‐di­methyl­thio‐1‐[3‐(4,6‐di­methyl­thio‐2H‐pyra­zolo­[3,4‐d]­py­rimi­din‐2‐yl)­propyl]‐1H‐py­ra­­zolo­[3,4‐d]­py­rimi­dine, C₁₇H₂₀N₈S₄, and 1‐[4‐(4‐meth­oxy‐6‐methyl­thio‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐1‐yl)­butyl]‐5‐meth­yl‐6‐methyl­thio‐4,5‐di­hydro‐1H‐pyra­zolo­[3,4‐d]py­rimi­din‐4‐one, C₁₈H₂₂N₈O₂S₂, only intermolecular stacking due to aromatic π–π interactions between pyrazolo­[3,4‐d]­pyrimidinerings is present.     

1‐[4‐(Methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole derivatives

Three related compounds containing a pyrazole moiety with vicinal phenyl rings featuring a methyl­sulfonyl substituent are described, namely 3‐methyl‐1‐[4‐(methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole, C₁₇H₁₆N₂O₂S, ethyl 1‐[4‐(methyl­sul­fonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole‐3‐carboxyl­ate, C₁₉H₁₈N₂O₄S, and 1‐[4‐(methyl­sulfonyl)­phenyl]‐3‐[3‐(morpholino)­phenoxy­methyl]‐5‐phenyl‐1H‐pyrazole, C₂₇H₂₇N₃O₄S. The design of these compounds was based on celecoxib, a selective cyclo­oxy­genase‐2 (COX‐2) inhibitor, in order to study the influence of various substituents on COX‐2 and 5‐lipoxy­genase (5‐LOX) inhibition.     

2‐{[Tris(hydroxymethyl)methyl]aminomethylene}cyclohexa‐3,5‐dien‐1(2H)‐one and its 6‐hydroxy and 6‐methoxy derivatives

The title compounds, 2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₁H₁₅NO₄, (I), 6‐hydroxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}­cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₁H₁₅NO₅, (II), and 6‐methoxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}­cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₂H₁₇NO₅, (III), adopt the keto–amine tautomeric form, with the formal hydroxy H atom located on the N atom, and the NH group and oxo O atom display a strong intramolecular N—H⋯O hydrogen bond. The N—H⋯O hydrogen‐bonded rings are almost planar and coupled with the cyclo­hexa­diene rings. The carbonyl O atoms accept two other H atoms from the alcohol groups of adjacent mol­ecules in (I), and one from the alcohol and one from the phenol group in (II), but from only one alcohol H atom in (III).     

20‐Di­cyano­methyl­ene‐5,8,11,14‐tetraoxa‐2,17‐di­thia­bi­cyclo­[16.4.1]­tricosa‐1(23),18,21‐triene and its mercury(II) dichloride complex

The structures of the title compound, C₂₀H₂₄N₂O₄S₂, and its mercury(II) dichloride complex, dichloro{20‐di­cyano­methyl­ene‐5,8,11,14‐tetraoxa‐2,17‐di­thia­bi­cyclo­[16.4.1]­tricosa‐1(23),18,­21‐tri­ene‐κ⁴O,κS¹⁷}mercury(II), [HgCl₂(C₂₀­H₂₄­N₂­O₄­S₂)], have been determined by X‐ray crystallographic analyses. The mercury(II) dichloride complex has two independent mol­ecules of [HgCl₂(C₂₀H₂₄N₂O₄S₂)] in the lattice. The mercury(II) ion has pentagonal bipyramidal coordination which involves one S atom, four O atoms and two Cl^? ions.